| Name | Rite Aid Pharmacy 10756 |
|---|---|
| Organization Name | Eckerd Corporation |
| Location | 1820 Teall Ave, Syracuse, New York 13206 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (315) 437-1531 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
Only one in three Australian women diagnosed with osteoporosis are aware they are at higher risk of sustaining debilitating bone fractures, according to a landmark international study published with input from University of Sydney researchers.
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
› Verified 2 days ago
| NPI Number | 1235239575 |
| Organization Name | ECKERD CORPORATION |
| Doing Business As | RITE AID PHARMACY 10756 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1820 Teall Avenue, Syracuse, NY 13206 |
| Phone Number | 315-437-1531 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
Only one in three Australian women diagnosed with osteoporosis are aware they are at higher risk of sustaining debilitating bone fractures, according to a landmark international study published with input from University of Sydney researchers.
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
› Verified 2 days ago
| NPI Number | 1477077162 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1820 Teall Ave, Syracuse, NY 13206 |
| Phone Number | 315-437-1531 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
Only one in three Australian women diagnosed with osteoporosis are aware they are at higher risk of sustaining debilitating bone fractures, according to a landmark international study published with input from University of Sydney researchers.
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
› Verified 2 days ago
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
Only one in three Australian women diagnosed with osteoporosis are aware they are at higher risk of sustaining debilitating bone fractures, according to a landmark international study published with input from University of Sydney researchers.
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
› Verified 2 days ago
Central New York Medical Products I Type: DME Supplier - Customized Equipment Location: 749 W Genesee St, Syracuse, New York 13204 Phone: (315) 428-9945 | |
Coram Healthcare Corporation Of Gre Type: Medicare Supplier Location: 2949 Erie Blvd E, Syracuse, New York 13224 Phone: (315) 425-8028 | |
Cvs Pharmacy #11238 Type: Pharmacy Location: 300 Gifford St, Syracuse, New York 13204 Phone: (315) 471-4139 | |
Cvs Pharmacy #17390 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3657 W Genesee St, Syracuse, New York 13219 Phone: (315) 233-0601 | |
Rite Aid Pharmacy 10756 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1820 Teall Ave, Syracuse, New York 13206 Phone: (315) 437-1531 |